Managing Increased Accessibility to Pharmacogenomic Data
نویسندگان
چکیده
منابع مشابه
Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies.
Gualberto Ruaño1,2, Jerry M Collins3, Andrew J Dorner4, Sue-Jane Wang5, Roberto Guerciolini6 & Shiew-Mei Huang†7 †Author for correspondence 1President, Genomas LLC, New Haven, CT, USA 2Department of Biochemistry and Molecular Biology, George Washington University, Washington DC, USA 3Director, Laboratory of Clinical Pharmacology, CDER, FDA, USA 4Senior Director, Molecular Medicine, Wyeth Resear...
متن کاملIncreased Content Accessibility For Wikis And Blogs
This paper aims to introduce a useful approach on the combined use of template based publishing tools (i.e. for blogs and wikis) and content personalization services. The approach considers that the original developers of web content have limited awareness on accessibility issues, and they are facilitated and guided by the editing interface. The publishing mechanism is responsible for storing w...
متن کاملSemantic triage for increased Web accessibility
S. Harper S. Bechhofer Visually impaired users are hindered in their efforts to access the largest repository of electronic information in the world, namely the World Wide Web. A visually impaired user’s information and presentation requirements are different from those of a sighted user, in that they are highly individualized and nonvisual. These requirements can become problems in that the We...
متن کاملOpen Accessibility Data Interlinking
This paper presents the research of using Linked Open Data to enhance accessibility data for accessible travelling. Open accessibility data is the data related to the accessibility issues associated with geographical data, which could benefit people with disabilities and their special needs. With the aim of addressing the gap between users’ special needs and data, this paper presents the result...
متن کاملPharmacogenomic Approaches to Asthma Treatment
Major classes of medication in asthma management include bronchodilating beta2-agonists, anti-inflammatory inhaled corticosteroids, leukotriene modifiers and theophyllines. However, all asthmatics do not respond to the same extent to a given medication. Available data suggest that a substantial range of individual variability, as much as 70%, may be due to genetic characteristics of each patien...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Clinical Pharmacology & Therapeutics
سال: 2019
ISSN: 0009-9236,1532-6535
DOI: 10.1002/cpt.1602